序号 |
标题 |
次数 |
作者 |
发布时间 |
86581 |
DOTA缀合肽M2pep DOTA-M2pep |
151 |
zcy |
2024-11-22 |
86582 |
CAS号:173308-19-5,DOTAMA(t-BuO)3-en |
97 |
kx |
2024-11-22 |
86583 |
3-(3,3,3-三氟-1-丙炔基)-2,2-二甲基环丙烷羧酸酯 |
101 |
WYQ |
2024-11-22 |
86584 |
DOTA-tris(TBE)-amido dPEG-MAL |
103 |
zyl |
2024-11-22 |
86585 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
107 |
kx |
2024-11-22 |
86586 |
DOTA-PEG-biotin DOTA-聚乙二醇-生物素 |
95 |
zcy |
2024-11-22 |
86587 |
DOTA-PEG(23)-bromoacetamide*2TFA |
104 |
zyl |
2024-11-22 |
86588 |
CAS号:219143-29-0,DOTA-(MeAm)4 |
104 |
kx |
2024-11-22 |
86589 |
DOTA(tBu3)-PEG(4)-TFP |
100 |
zyl |
2024-11-22 |
86590 |
DOTA-MBP 齐岳定制 |
115 |
zcy |
2024-11-22 |
86591 |
CAS号:293295-66-6,Y-DOTA-TOC |
90 |
kx |
2024-11-22 |
86592 |
CAS:2792156-83-1 IPB-K(DOTA)-FAPI |
97 |
zyl |
2024-11-22 |
86593 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-Ser-Ser-Ser-LTVSPWY |
110 |
zcy |
2024-11-22 |
86594 |
CAS号:474424-15-2,dota-pnp |
104 |
kx |
2024-11-22 |
86595 |
CU-64 DOTA-TATE |
116 |
zyl |
2024-11-22 |
86596 |
DOTA-hLL2 螯合剂DOTA偶联人源化抗体hLL2 |
119 |
zcy |
2024-11-22 |
86597 |
DOTA-PSMA-EB-01 |
104 |
zyl |
2024-11-22 |
86598 |
1610950-41-8,DOTA-MeTz,DOTA-甲基四嗪 |
105 |
kx |
2024-11-22 |
86599 |
p-NCS-benzyl-DOTA p-NCS-苄基-DOTA |
152 |
zcy |
2024-11-22 |
86600 |
1189194-64-6,DOTA-(COOt-Bu)3-CH2-Alkynyl |
87 |
kx |
2024-11-22 |
86601 |
DOTA-cyclo(RGDfK);DOTA-RGD |
102 |
wyh |
2024-11-22 |
86602 |
CuAAC修饰的DOTAZA 齐岳定制 |
124 |
zcy |
2024-11-22 |
86603 |
1039726-31-2,DOTA-JR-11 |
88 |
kx |
2024-11-22 |
86604 |
zher2-HSA-DOTA DOTA螯合剂偶联ZHER2支架多肽缀合人血清白蛋白 |
133 |
zcy |
2024-11-22 |
86605 |
CAS:1800229-46-2 Maleimide-DOTA-GA |
101 |
zyl |
2024-11-22 |
86606 |
panitumumab-DOTA DOTA标记的抗EGFR帕尼单抗 |
101 |
zcy |
2024-11-22 |
86607 |
DOTA-CH2-Ph-azide(HCl salt) |
97 |
kx |
2024-11-22 |
86608 |
DOTA-三(酸) - 酰氨基-DPEG(R)11-马来酰亚胺 |
114 |
zyl |
2024-11-22 |
86609 |
DOTA-Glu「cyclo(Arg-Gly-Asp-D-Phe-Lys)」2 |
102 |
kx |
2024-11-22 |
86610 |
CAS:834870-39-2 DOTA series |
111 |
zyl |
2024-11-22 |
86611 |
DOTA-cyclo(RGDfK);DOTA-RGD |
104 |
wyh |
2024-11-22 |
86612 |
DOTA-PEG-SH、DOTA-PEG-Thiol的结构组成 |
101 |
kx |
2024-11-22 |
86613 |
DTPA-bis anhydride,二亚乙基三胺五乙酸二酐 |
113 |
wyh |
2024-11-22 |
86614 |
NOTA-PEG5000-Mal ;NOTA PEG5 马来酰亚胺 |
83 |
wyh |
2024-11-22 |
86615 |
DOTA-E「c(RGDfK)2」 |
93 |
kx |
2024-11-22 |
86616 |
DOTA-L-Lys(SA。Pam)-PSMA-617 DOTA偶联二膦酸盐和PSMA抑制剂 |
108 |
zcy |
2024-11-22 |
86617 |
DOTA-E[c(RGDfK)2]的应用领域 |
116 |
kx |
2024-11-22 |
86618 |
DOTA-氟喹诺酮衍生物 DOTA-fluoroquinolone derivatives |
91 |
zcy |
2024-11-22 |
86619 |
DOTA-NHS |
159 |
kx |
2024-11-22 |
86620 |
p-SCN-Bn-DTPA,102650-30-6,1-(4-异硫氰酸酯)二乙炔三胺 |
96 |
wyh |
2024-11-22 |
86621 |
NOTA-PEG-RGD |
92 |
kx |
2024-11-22 |
86622 |
三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸;137076-54-1 |
125 |
wyh |
2024-11-22 |
86623 |
DOTA-PEG-CRGD的结构组成、应用领域 |
89 |
kx |
2024-11-22 |
86624 |
DOTA-MWCNT-Gd DOTA钆配合物修饰多壁碳纳米管 |
93 |
zcy |
2024-11-22 |
86625 |
817562-90-6,(R)-tert-Bu4-DOTAGA,(R)-DOTAGA-四叔丁酯 |
85 |
kx |
2024-11-22 |